Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
roberta.renie@uniroma1.it
Roberta Renie'
Dottorando
Struttura:
DIPARTIMENTO DI PSICOLOGIA
E-mail:
roberta.renie@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome
SCIENTIFIC REPORTS
2022
Late-Onset MS: Disease Course and Safety-Efficacy of DMTS
FRONTIERS IN NEUROLOGY
2022
Mait cells and microbiota in multiple sclerosis and other autoimmune diseases
MICROORGANISMS
2021
A case of double standard. Sex differences in multiple sclerosis risk factors
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate
FRONTIERS IN NEUROLOGY
2021
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
FRONTIERS IN IMMUNOLOGY
2021
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies
EBIOMEDICINE
2021
Disentangling the molecular mechanisms of multiple sclerosis: the contribution of twin studies
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
2020
SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets
F1000RESEARCH
2020
The contribution of gut barrier changes to multiple sclerosis pathophysiology
FRONTIERS IN IMMUNOLOGY
2019
Autoimmune encephalitis and CSF anti-glur3 antibodies in an MS patient after alemtuzumab treatment
BRAIN SCIENCES
2019
Chapter 3 - Bacille Calmette-Guérin (BCG) Vaccine in Neuroinflammation
The Value of BCG and TNF in Autoimmunity
2018
Coincident onset of multiple sclerosis and herpes simplex virus 1 encephalitis. a case report
MULTIPLE SCLEROSIS AND DEMYELINATING DISORDERS
2017
Neuropsychological predictors of rapidly progressive Alzheimer's disease
ACTA NEUROLOGICA SCANDINAVICA
2015
Sociodemographic and clinical changes over time of individuals evaluated for cognitive disturbances: good or bad news?
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION
2015
Progetti di Ricerca
Effectiveness of Siponimod in Progressive - Active multiple sclerosis. Could it have a role as in neuroprotective and remyelinating agent? A pilot Study
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma